Infective endocarditis in the XXI century: Epidemiological, therapeutic, and prognosis changes;La endocarditis infecciosa en el siglo xxi: Cambios epidemiológicos, terapéuticos y pronósticos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 7, 2012, Pages 394-406

  Fernández Hidalgo, Nuria ^a,b   Almirante, Benito ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bias; Endocarditis; Epidemiology; Etiology; Health care; Incidence; Outcome; Risk factors; Surgery; Therapy

Indexed keywords

CLOXACILLIN;

ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; DEGENERATIVE DISEASE; DEVELOPED COUNTRY; DISEASE SEVERITY; ENTEROCOCCUS; HEALTH CARE SYSTEM; HOSPITAL INFECTION; MORTALITY; PROGNOSIS; STAPHYLOCOCCUS AUREUS; VALVULAR HEART DISEASE;

EID: 84864628030     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.11.005     Document Type: Review

References (145)

1. G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, and I. Vilacosta Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer Eur Heart J 30 2009 Oct 2369 2413
2. L.M. Baddour, W.R. Wilson, A.S. Bayer, V.G. Fowler Jr., A.F. Bolger, and M.E. Levison Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America Circulation 111 2005 Jun 14 e394 e434
3. F. Delahaye, B. Harbaoui, V. Cart-Regal, and G. De Gevigney Recommendations on prophylaxis for infective endocarditis: dramatic changes over the past seven years Arch Cardiovasc Dis 102 2009 Mar 233 245
4. X. Duval, and C. Leport Prophylaxis of infective endocarditis: current tendencies, continuing controversies Lancet Infect Dis 8 2008 Apr 225 232 (Pubitemid 351384827)
5. Y.A. Que, and P. Moreillon Infective endocarditis Nat Rev Cardiol 8 2011 Jun 322 336
6. F. Thuny, J.F. Avierinos, and G. Habib Changing patterns in epidemiological profiles and prevention strategies in infective endocarditis: from teeth to healthcare-related infection Eur Heart J 31 2010 Aug 1826 1827
7. B.D. Prendergast The changing face of infective endocarditis Heart 92 2006 Jul 879 885 (Pubitemid 43974043)
8. E. Cecchi, M. Imazio, and R. Trinchero The changing face of infective endocarditis Heart 92 2006 Oct 1365 1366 (Pubitemid 44578817)
9. B. Hoen, F. Alla, C. Selton-Suty, I. Beguinot, A. Bouvet, and S. Briancon Changing profile of infective endocarditis: results of a 1-year survey in France JAMA 288 2002 Jul 3 75 81 (Pubitemid 34705521)
10. V.G. Fowler Jr., J.M. Miro, B. Hoen, C.H. Cabell, E. Abrutyn, and E. Rubinstein Staphylococcus aureus endocarditis: a consequence of medical progress JAMA 293 2005 Jun 22 3012 3021 (Pubitemid 40965071)
11. D.R. Murdoch, G.R. Corey, B. Hoen, J.M. Miro, V.G. Fowler Jr., and A.S. Bayer Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med 169 2009 Mar 9 463 473
12. P. Tornos, T. Gonzalez-Alujas, F. Thuny, and G. Habib Infective endocarditis: the European viewpoint Curr Probl Cardiol 36 2011 May 175 222
13. N. Fernandez-Hidalgo, B. Almirante, P. Tornos, C. Pigrau, A. Sambola, and A. Igual Contemporary epidemiology and prognosis of health care-associated infective endocarditis Clin Infect Dis 47 2008 Nov 15 1287 1297
14. R. Richey, D. Wray, and T. Stokes Prophylaxis against infective endocarditis: summary of NICE guidance BMJ 336 2008 Apr 5 770 771 (Pubitemid 351507408)
15. R.W. Sy, and L. Kritharides Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia Eur Heart J 31 2010 Aug 1890 1897
16. J. Lopez, A. Revilla, I. Vilacosta, T. Sevilla, E. Villacorta, and C. Sarria Age-dependent profile of left-sided infective endocarditis: a 3-center experience Circulation 121 2010 Feb 23 892 897
17. M.L. Fernandez Guerrero, L.J. Gonzalez, and M. Gorgolas Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient Eur J Clin Microbiol Infect Dis 29 2010 Oct 1271 1275
18. S. Rekik, I. Trabelsi, M. Hentati, A. Hammami, M.B. Jemaa, and J. Hachicha Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis Clin Exp Nephrol 13 2009 Aug 350 354
19. A. Revilla, J. Lopez, E. Villacorta, I. Gomez, T. Sevilla, and M.A. Del Pozo Isolated right-sided valvular endocarditis in non-intravenous drug users Rev Esp Cardiol 61 2008 Dec 1253 1259
20. Ribera E, Martinez-Costa X, Tornos P, Gomez-Jimenez J, Planes A, Pahissa A, et al. [Infectious endocarditis in drug addicts: a study of 71 cases]. Med Clin (Barc) 1990 Jun 2;95:5-9.
21. T. Sevilla, A. Revilla, J. Lopez, I. Vilacosta, C. Sarria, and I. Gomez Influence of Sex on Left-Sided Infective Endocarditis Rev Esp Cardiol 63 2010 Dec 1497 1500
22. W. Osler Chronic infective endocarditis Q J Med 2 1909 219 230
23. H. Nissen, P.F. Nielsen, M. Frederiksen, C. Helleberg, and J.S. Nielsen Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980 Eur Heart J 13 1992 Jul 872 877
24. F. Delahaye, V. Goulet, F. Lacassin, R. Ecochard, C. Selton-Suty, and B. Hoen Characteristics of infective endocarditis in France in 1991. A 1-year survey Eur Heart J 16 1995 Mar 394 401
25. C.H. Cabell, J.G. Jollis, G.E. Peterson, G.R. Corey, D.J. Anderson, and D.J. Sexton Changing patient characteristics and the effect on mortality in endocarditis Arch Intern Med 162 2002 Jan 14 90 94 (Pubitemid 34073406)
26. B. Hoen Epidemiology and antibiotic treatment of infective endocarditis: an update Heart 92 2006 Nov 1694 1700 (Pubitemid 44642122)
27. M.H. Thornhill, M.J. Dayer, J.M. Forde, G.R. Corey, V.H. Chu, and D.J. Couper Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study BMJ 342 2011 d2392
28. U. Fedeli, E. Schievano, D. Buonfrate, G. Pellizzer, and P. Spolaore Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system BMC Infect Dis 11 2011 48
29. J. Galvez-Acebal, J. Rodriguez-Bano, F.J. Martinez-Marcos, J.M. Reguera, A. Plata, and J. Ruiz Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort BMC Infect Dis 10 2010 17
30. P. Tornos [Infective endocarditis: a serious and rare condition that needs to be handled in experienced hospitals] Rev Esp Cardiol 58 2005 Oct 1145 1147 (Pubitemid 41715564)
31. E. Botelho-NeverS, F. Thuny, J.P. Casalta, H. Richet, F. Gouriet, and F. Collart Dramatic reduction in infective endocarditis-related mortality with a management-based approach Arch Intern Med 169 2009 Jul 27 1290 1298
32. M. Lopez-Dupla, S. Hernandez, M. Olona, J. Merce, A. Lorenzo, and J. Tapiol [Clinical characteristics and outcome of infective endocarditis in individuals of the general population managed at a teaching hospital without cardiac surgery facilities. Study of 120 cases] Rev Esp Cardiol 59 2006 Nov 1131 1139 (Pubitemid 46139211)
33. N. Fernandez-Hidalgo, B. Almirante, P. Tornos, M.T. Gonzalez-Alujas, A.M. Planes, and M.N. Larrosa Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital-prospective analysis of referral bias and influence of inadequate antimicrobial treatment Clin Microbiol Infect 17 2011 May 769 775
34. J.M. Steckelberg, L.J. Melton III, D.M. Ilstrup, M.S. Rouse, and W.R. Wilson Influence of referral bias on the apparent clinical spectrum of infective endocarditis Am J Med 88 1990 Jun 582 588 (Pubitemid 20192269)
35. Z.A. Kanafani, S.S. Kanj, C.H. Cabell, E. Cecchi, R.A. De Oliveira, and T. Lejko-Zupanc Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults Eur J Clin Microbiol Infect Dis 29 2010 Oct 1203 1210
36. S. Morpeth, D. Murdoch, C.H. Cabell, A.W. Karchmer, P. Pappas, and D. Levine Non-HACEK gram-negative bacillus endocarditis Ann Intern Med 147 2007 Dec 18 829 835 (Pubitemid 351664422)
37. P. Brouqui, and D. Raoult Endocarditis due to rare and fastidious bacteria Clin Microbiol Rev 14 2001 Jan 177 207 (Pubitemid 32096213)
38. P.E. Fournier, F. Thuny, H. Richet, H. Lepidi, J.P. Casalta, and J.P. Arzouni Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases Clin Infect Dis 51 2010 Jul 15 131 140
39. P. Moreillon, Y.A. Que, and A.S. Bayer Pathogenesis of streptococcal and staphylococcal endocarditis Infect Dis Clin North Am 16 2002 Jun 297 318 (Pubitemid 34663638)
40. W.E. Stehbens, B. Delahunt, and J.M. Zuccollo The histopathology of endocardial sclerosis Cardiovasc Pathol 9 2000 May 161 173
41. P. Sidhu, H. O'Kane, N. Ali, D.J. Gladstone, M.A. Sarsam, and G. Campalani Mechanical or bioprosthetic valves in the elderly: a 20-year comparison Ann Thorac Surg 71 5 Suppl 2001 May S257 S260
42. E. Varstela Personal follow-up of 100 aortic valve replacement patients for 1081 patient years Ann Chir Gynaecol 87 1998 205 212
43. J. Lopez, A. Revilla, I. Vilacosta, E. Villacorta, C. Gonzalez-Juanatey, and I. Gomez Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis Eur Heart J 28 2007 Mar 760 765 (Pubitemid 46439227)
44. C.H. Cabell, P.A. Heidenreich, V.H. Chu, C.M. Moore, M.E. Stryjewski, and G.R. Corey Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999 Am Heart J 147 2004 Apr 582 586 (Pubitemid 38900441)
45. C. Zhan, W.B. Baine, A. Sedrakyan, and C. Steiner Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis J Gen Intern Med 23 Suppl 1 2008 Jan 13 19 (Pubitemid 350295396)
46. X. Duval, C. Selton-Suty, F. Alla, M. Salvador-Mazenq, Y. Bernard, and M. Weber Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection Clin Infect Dis 39 2004 Jul 1 68 74 (Pubitemid 38879551)
47. L.M. Baddour, A.E. Epstein, C.C. Erickson, B.P. Knight, M.E. Levison, and P.B. Lockhart Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association Circulation 121 2010 Jan 26 458 477
48. P. Martin-Davila, J. Fortun, E. Navas, J. Cobo, M. Jimenez-Mena, and J.L. Moya Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases Chest 128 2005 Aug 772 779 (Pubitemid 41140507)
49. E. Giannitsioti, I. Skiadas, A. Antoniadou, S. Tsiodras, K. Kanavos, and H. Triantafyllidi Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk Clin Microbiol Infect 13 2007 Aug 763 769 (Pubitemid 47039908)
50. M.L. Fernandez-Guerrero, C. Verdejo, J. Azofra, and M. De Górgolas Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem Clin Infect Dis 20 1995 Jan 16 23
51. W. Osler The Gulstonian Lectures, on Malignant Endocarditis Br Med J 1 1885 Mar 21 577 579
52. N. Benito, J.M. Miro, E. De Lazzari, C.H. Cabell, A. Del Río, and J. Altclas Health care-associated native valve endocarditis: importance of non-nosocomial acquisition Ann Intern Med 150 2009 May 5 586 594
53. J.M. Lomas, F.J. Martinez-Marcos, A. Plata, R. Ivanova, J. Galvez, and J. Ruiz Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization Clin Microbiol Infect 16 2010 Nov 1683 1690
54. T. Doulton, N. Sabharwal, H.S. Cairns, S. Schelenz, S. Eykyn, and P. O'Donnell Infective endocarditis in dialysis patients: new challenges and old Kidney Int 64 2003 Aug 720 727 (Pubitemid 36871947)
55. K.C. Abbott, and L.Y. Agodoa Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States Nephron 91 2002 Jun 203 209 (Pubitemid 34621684)
56. J.T. McCarthy, and J.M. Steckelberg Infective endocarditis in patients receiving long-term hemodialysis Mayo Clin Proc 75 2000 Oct 1008 1014
57. S. Maraj, L.E. Jacobs, S.C. Kung, R. Raja, P. Krishnasamy, and R. Maraj Epidemiology and outcome of infective endocarditis in hemodialysis patients Am J Med Sci 324 2002 Nov 254 260 (Pubitemid 35278770)
58. E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.F. Tripodi, B. Barsic, and E. Bouza Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med 168 2008 Oct 27 2095 2103
59. Fernandez Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, De Górgolas M. Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome. Medicine (Baltimore) 2007 Nov;86:363-77.
60. N. Peled, S. Pitlik, G. Livni, S. Ashkenazi, and J. Bishara Impact of age on clinical features and outcome of infective endocarditis Eur J Clin Microbiol Infect Dis 25 2006 Jul 473 475 (Pubitemid 44078601)
61. I. Perez d, J.L. Zamorano, C. Almeria, J.L. Rodrigo, I. Piedra, and A. Aubele [Infective endocarditis in patients with chronic liver disease: clinical and prognostic assessment] Rev Esp Cardiol 56 2003 Aug 794 800 (Pubitemid 37193052)
62. S. Bakir, T. Mori, J. Durand, Y.F. Chen, J.A. Thompson, and S. Oparil Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model Circulation 101 2000 May 23 2342 2344 (Pubitemid 30329121)
63. A. Sambola, N. Fernandez-Hidalgo, B. Almirante, I. Roca, T. Gonzalez-Alujas, and B. Serra Sex differences in native-valve infective endocarditis in a single tertiary-care hospital Am J Cardiol 106 2010 Jul 1 92 98
64. O. Aksoy, L.T. Meyer, C.H. Cabell, W.M. Kourany, P.A. Pappas, and D.J. Sexton Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients Scand J Infect Dis 39 2007 101 107 (Pubitemid 46277308)
65. B.L. Strom, E. Abrutyn, J.A. Berlin, J.L. Kinman, R.S. Feldman, and P.D. Stolley Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study Ann Intern Med 129 1998 Nov 15 761 769 (Pubitemid 28522810)
66. F. Lacassin, B. Hoen, C. Leport, C. Selton-Suty, F. Delahaye, and V. Goulet Procedures associated with infective endocarditis in adults. A case control study Eur Heart J 16 1995 Dec 1968 1974
67. J.T. Van der Meer, W. Van Wijk, J. Thompson, J.P. Vandenbroucke, H.A. Valkenburg, and M.F. Michel Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis Lancet 339 1992 Jan 18 135 139
68. L. Forner, T. Larsen, M. Kilian, and P. Holmstrup Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation J Clin Periodontol 33 2006 Jun 401 407 (Pubitemid 43742620)
69. G.J. Roberts Dentists are innocent! Everyday bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children Pediatr Cardiol 20 1999 Sep 317 325 (Pubitemid 29383369)
70. NICE. Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures [consultado 13 Dic 2011]. Disponible en: http://guidance.nice.org.uk/CG64
71. P. Moreillon, and Y.A. Que Infective endocarditis Lancet 363 2004 Jan 10 139 149 (Pubitemid 38068333)
72. E. Widmer, Y.A. Que, J.M. Entenza, and P. Moreillon New concepts in the pathophysiology of infective endocarditis Curr Infect Dis Rep 8 2006 Jun 271 279 (Pubitemid 44069996)
73. A.C. Cremieux, B. Maziere, J.M. Vallois, M. Ottaviani, A. Azancot, and H. Raffoul Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography J Infect Dis 159 1989 May 938 944 (Pubitemid 19113081)
74. T.S. Elliott, J. Foweraker, F.K. Gould, J.D. Perry, and J.A. Sandoe Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy J Antimicrob Chemother 54 2004 Dec 971 981 (Pubitemid 40136728)
75. D.R. Ramsdale, and L. Turner-Stokes Prophylaxis and treatment of infective endocarditis in adults: a concise guide Clin Med 4 2004 Nov 545 550 (Pubitemid 40070277)
76. K. Westling, E. Aufwerber, C. Ekdahl, G. Friman, B. Gardlund, and I. Julander Swedish guidelines for diagnosis and treatment of infective endocarditis Scand J Infect Dis 39 2007 11 12 929-46
77. R.A. Nishimura, B.A. Carabello, D.P. Faxon, M.D. Freed, B.W. Lytle, and P.T. O'Gara ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 Aug 19 887 896
78. R.B. Hsu, and F.Y. Lin Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis Cardiology 105 2006 234 239
79. B. Knoll, I.M. Tleyjeh, J.M. Steckelberg, W.R. Wilson, and L.M. Baddour Infective endocarditis due to penicillin-resistant viridans group streptococci Clin Infect Dis 44 2007 Jun 15 1585 1592 (Pubitemid 46871505)
80. D.S. Stein, and K.E. Nelson Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma Rev Infect Dis 9 1987 Sep 908 916
81. C.H. Lin, and R.B. Hsu Infective endocarditis caused by nutritionally variant streptococci Am J Med Sci 334 2007 Oct 235 239
82. L. Senn, J.M. Entenza, G. Greub, K. Jaton, A. Wenger, and J. Bille Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species BMC Infect Dis 6 2006 9
83. L.M. Baddour Infective endocarditis caused by beta-hemolytic streptococci. The Infectious Diseases Society of America's Emerging Infections Network Clin Infect Dis 26 1998 Jan 66 71
84. A. Lefort, O. Lortholary, P. Casassus, C. Selton-Suty, L. Guillevin, and J.L. Mainardi Comparison between adult endocarditis due to beta-hemolytic streptococci (serogroups A, B, C, and G) and Streptococcus milleri: a multicenter study in France Arch Intern Med 162 2002 Nov 25 2450 2456 (Pubitemid 35340461)
85. A. Sambola, J.M. Miro, M.P. Tornos, B. Almirante, A. Moreno-Torrico, and M. Gurgui Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998 Clin Infect Dis 34 2002 Jun 15 1576 1584 (Pubitemid 34615442)
86. J.R. McDonald, L. Olaison, D.J. Anderson, B. Hoen, J.M. Miro, and S. Eykyn Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database Am J Med 118 2005 Jul 759 766 (Pubitemid 40897662)
87. R.C. Moellering Jr., O.M. Korzeniowski, M.A. Sande, and C.B. Wennersten Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis J Infect Dis 140 1979 Aug 203 208 (Pubitemid 10243091)
88. R. Fontana, P. Canepari, M.M. Lleo, and G. Satta Mechanisms of resistance of enterococci to beta-lactam antibiotics Eur J Clin Microbiol Infect Dis 9 1990 Feb 103 105 (Pubitemid 20074227)
89. B.E. Murray Beta-lactamase-producing enterococci Antimicrob Agents Chemother 36 1992 Nov 2355 2359
90. Y.Y. Chou, T.Y. Lin, J.C. Lin, N.C. Wang, M.Y. Peng, and F.Y. Chang Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis J Microbiol Immunol Infect 41 2008 Apr 124 129
91. J.L. Mainardi, L. Gutmann, J.F. Acar, and F.W. Goldstein Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis Antimicrob Agents Chemother 39 1995 Sep 1984 1987
92. J. Gavalda, C. Torres, C. Tenorio, P. Lopez, M. Zaragoza, and J.A. Capdevila Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides Antimicrob Agents Chemother 43 1999 Mar 639 646 (Pubitemid 29109532)
93. J. Gavalda, P.L. Onrubia, M.T. Gomez, X. Gomis, J.L. Ramirez, and O. Len Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides J Antimicrob Chemother 52 2003 Sep 514 517 (Pubitemid 37120740)
94. L. Olaison, and K. Schadewitz Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 34 2002 Jan 15 159 166 (Pubitemid 34028346)
95. J. Gavalda, O. Len, J.M. Miro, P. Munoz, M. Montejo, and A. Alarcon Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone Ann Intern Med 146 2007 Apr 17 574 579 (Pubitemid 351650538)
96. F. Caron, M.D. Kitzis, L. Gutmann, A.C. Cremieux, B. Maziere, and J.M. Vallois Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium Antimicrob Agents Chemother 36 1992 Dec 2611 2616
97. M. Venditti, A. Tarasi, A. Capone, M. Galie, F. Menichetti, and P. Martino Teicoplanin in the treatment of enterococcal endocarditis: clinical and microbiological study J Antimicrob Chemother 40 1997 Sep 449 452 (Pubitemid 27437970)
98. R. Canton, P. Ruiz-Garbajosa, R.L. Chaves, and A.P. Johnson A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother 65 2010 Jun 1126 1136
99. J. Abraham, C. Mansour, E. Veledar, B. Khan, and S. Lerakis Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia Am Heart J 147 2004 Mar 536 539 (Pubitemid 38880879)
100. J.M. Miro, I. Anguera, C.H. Cabell, A.Y. Chen, J.A. Stafford, and G.R. Corey Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database Clin Infect Dis 41 2005 Aug 15 507 514 (Pubitemid 41099645)
101. J.P. Remadi, G. Habib, G. Nadji, A. Brahim, F. Thuny, and J.P. Casalta Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis Ann Thorac Surg 83 2007 Apr 1295 1302 (Pubitemid 46440736)
102. V.G. Fowler Jr., H.W. Boucher, G.R. Corey, E. Abrutyn, A.W. Karchmer, and M.E. Rupp Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 2006 Aug 17 653 665
103. D.P. Levine, and K.C. Lamp Daptomycin in the treatment of patients with infective endocarditis: experience from a registry Am J Med 120 10 Suppl 1 2007 Oct S28 S33
104. B. Almirante [Clinical experience with daptomycin use in Spain. Global findings from EU-CORE database] Med Clin (Barc) 135 Suppl 3 2010 Dec 23 28
105. W.E. Rose, M.J. Rybak, and G.W. Kaatz Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies J Antimicrob Chemother 60 2007 Aug 334 340 (Pubitemid 47243883)
106. W.E. Rose, S.N. Leonard, G. Sakoulas, G.W. Kaatz, M.J. Zervos, and A. Sheth daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations Antimicrob Agents Chemother 52 2008 Mar 831 836 (Pubitemid 351358359)
107. G. Sakoulas, P.A. Moise-Broder, J. Schentag, A. Forrest, R.C. Moellering Jr., and G.M. Eliopoulos Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2004 Jun 2398 2402 (Pubitemid 38747480)
108. P.A. Moise-Broder, G. Sakoulas, G.M. Eliopoulos, J.J. Schentag, A. Forrest, and R.C. Moellering Jr. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy Clin Infect Dis 38 2004 Jun 15 1700 1705 (Pubitemid 38781661)
109. I.M. Gould Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus Int J Antimicrob Agents 31 Suppl 2 2008 Apr 1 9 (Pubitemid 351657677)
110. S.K. Fridkin, J. Hageman, L.K. McDougal, J. Mohammed, W.R. Jarvis, and T.M. Perl Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001 Clin Infect Dis 36 2003 Feb 15 429 439 (Pubitemid 36241308)
111. B.P. Howden, P.B. Ward, P.G. Charles, T.M. Korman, A. Fuller, and P. Du Cros Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility Clin Infect Dis 38 2004 Feb 15 521 528 (Pubitemid 38250962)
112. P.A. Moise, G. Sakoulas, A. Forrest, and J.J. Schentag Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia Antimicrob Agents Chemother 51 2007 Jul 2582 2586 (Pubitemid 47047340)
113. D.O. Maclayton, K.J. Suda, K.A. Coval, C.B. York, and K.W. Garey Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis Clin Ther 28 2006 Aug 1208 1216 (Pubitemid 44374748)
114. A. Soriano, F. Marco, J.A. Martinez, E. Pisos, M. Almela, and V.P. Dimova Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2008 Jan 15 193 200 (Pubitemid 351269157)
115. L.K. Hidayat, D.I. Hsu, R. Quist, K.A. Shriner, and A. Wong-Beringer High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity Arch Intern Med 166 2006 Oct 23 2138 2144 (Pubitemid 44631403)
116. T.P. Lodise, B. Lomaestro, J. Graves, and G.L. Drusano Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity Antimicrob Agents Chemother 52 2008 Apr 1330 1336 (Pubitemid 351521995)
117. F. Gudiol, J.M. Aguado, A. Pascual, M. Pujol, B. Almirante, and J.M. Miro [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica] Enferm Infecc Microbiol Clin 27 2009 Feb 105 115
118. C. Liu, A. Bayer, S.E. Cosgrove, R.S. Daum, S.K. Fridkin, and R.J. Gorwitz Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 Feb 1 e18 e55
119. S.J. Rehm, H. Boucher, D. Levine, M. Campion, B.I. Eisenstein, and G.A. Vigliani Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates J Antimicrob Chemother 62 2008 Dec 1413 1421
120. K. Credito, G. Lin, and P.C. Appelbaum Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology Antimicrob Agents Chemother 51 2007 Apr 1504 1507 (Pubitemid 46586838)
121. J.M. Miro, C. Garcia-de-la-Maria, Y. Armero, D. Soy, A. Moreno, and A. Del Río Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 Oct 4172 4177
122. M. Benvenuto, D.P. Benziger, S. Yankelev, and G. Vigliani Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers Antimicrob Agents Chemother 50 2006 Oct 3245 3249 (Pubitemid 44527494)
123. D.A. Figueroa, E. Mangini, M. Amodio-Groton, B. Vardianos, A. Melchert, and C. Fana Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program Clin Infect Dis 49 2009 Jul 15 177 180
124. A. Dhand, A.S. Bayer, J. Pogliano, S.J. Yang, M. Bolaris, and V. Nizet Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding Clin Infect Dis 53 2011 Jul 15 158 163
125. Cervera C, Castaneda X, Pericas JM, Del Río A, de la Maria CG, Mestres C, et al. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci. Int J Antimicrob Agents 2011 Mar 18.
126. S. Andrade-Baiocchi, M.C. Tognim, O.C. Baiocchi, and H.S. Sader Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization Diagn Microbiol Infect Dis 45 2003 Feb 149 152 (Pubitemid 36263029)
127. F. Thuny, and G. Habib When should we operate on patients with acute infective endocarditis? Heart 96 2010 Jun 892 897
128. P. Tornos, B. Iung, G. Permanyer-Miralda, G. Baron, F. Delahaye, and C. Gohlke-Barwolf Infective endocarditis in Europe: lessons from the Euro heart survey Heart 91 2005 May 571 575 (Pubitemid 40559341)
129. B.D. Prendergast, and P. Tornos Surgery for infective endocarditis: who and when? Circulation 121 2010 Mar 9 1141 1152
130. H.R. Vikram, J. Buenconsejo, R. Hasbun, and V.J. Quagliarello Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis JAMA 290 2003 Dec 24 3207 3214 (Pubitemid 38020682)
131. O. Aksoy, D.J. Sexton, A. Wang, P.A. Pappas, W. Kourany, and V. Chu Early surgery in patients with infective endocarditis: a propensity score analysis Clin Infect Dis 44 2007 Feb 1 364 372 (Pubitemid 46147618)
132. I.M. Tleyjeh, J.M. Steckelberg, G. Georgescu, H.M. Ghomrawi, T.L. Hoskin, and F.B. Enders The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis Heart 94 2008 Jul 892 896 (Pubitemid 351914701)
133. F. Thuny, S. Beurtheret, J. Mancini, V. Gariboldi, J.P. Casalta, and A. Riberi The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis Eur Heart J 32 2011 Aug 2027 2033
134. T. Lalani, C.H. Cabell, D.K. Benjamin, O. Lasca, C. Naber, and V.G. Fowler Jr. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias Circulation 121 2010 Mar 2 1005 1013
135. J.A. San Roman, J. Lopez, A. Revilla, I. Vilacosta, P. Tornos, and B. Almirante Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): a multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis Am Heart J 156 2008 Sep 431 436
136. E.A. Shinebourne, C.M. Cripps, G.W. Hayward, and R.A. Shooter Bacterial endocarditis 1956-1965: analysis of clinical features and treatment in relation to prognosis and mortality Br Heart J 31 1969 Sep 536 542
137. Malquarti V, Saradarian W, Etienne J, Milon H, Delahaye JP. Prognosis of native valve infective endocarditis: a review of 253 cases. Eur Heart J 1984 Oct;5 Suppl C:11-20. (Pubitemid 15187433)
138. J.A. Lowes, J. Hamer, G. Williams, E. Houang, S. Tabaqchali, and E.J. Shaw 10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality Lancet 1 1980 Jan 19 133 136 (Pubitemid 10193050)
139. A.R. Marra, R.G. Cal, M.S. Durao, L. Correa, L.R. Guastelli, and D.F. Moura Jr. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era Am J Infect Control 38 2010 Aug 434 439
140. M.M. Palomar, L.F. Alvarez, M.A. Riera Badia, G.C. Leon, M.J. Lopez Pueyo, and T.C. Diaz [Prevention of bacteriema related with ICU catheters by multifactorial intervention: a report of the pilot study] Med Intensiva 34 2010 Dec 581 589
141. J.A. San Roman, J. Lopez, I. Vilacosta, M. Luaces, C. Sarria, and A. Revilla Prognostic stratification of patients with left-sided endocarditis determined at admission Am J Med 120 2007 Apr 369 377
142. Lopez J, Fernandez-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart. 2011;97:1138-42.
143. P. Tornos, B. Almirante, S. Mirabet, G. Permanyer, A. Pahissa, and J. Soler-Soler Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy Arch Intern Med 159 1999 Mar 8 473 475 (Pubitemid 29108912)
144. V. Goulet, J. Etienne, J. Fleurette, and R. Netter [Infectious endocarditis in France. Epidemiological characteristics] Presse Med 15 1986 Oct 25 1855 1858 (Pubitemid 17175360)
145. D.D. De Sa, I.M. Tleyjeh, N.S. Anavekar, J.C. Schultz, J.M. Thomas, and B.D. Lahr Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota Mayo Clin Proc 85 2010 May 422 426